trending Market Intelligence /marketintelligence/en/news-insights/trending/mwpcZePUGepzrrrDpfknrA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Report: Centerbridge considers selling US benefits provider Versant Health

Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks


Report: Centerbridge considers selling US benefits provider Versant Health

Centerbridge Partners LP is considering selling U.S. managed vision care benefits company Versant Health Inc., Reuters reported, citing people familiar with the matter.

The New York-based buyout firm has tapped Barclays PLC to manage the sales process of the company, which could notch a valuation of more than $2 billion, including debt, the sources said.

Other medical benefits providers and private equity firms could emerge as potential suitors of the business, the report noted.

Versant and Barclays did not comment on the potential deal, while Centerbridge did not answer Reuters' request for comment.